These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7878032)

  • 1. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.
    Douce G; Turcotte C; Cropley I; Roberts M; Pizza M; Domenghini M; Rappuoli R; Dougan G
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1644-8. PubMed ID: 7878032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.
    Park EJ; Chang JH; Kim JS; Yum JS; Chung SI
    Exp Mol Med; 2000 Jun; 32(2):72-8. PubMed ID: 10926118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity.
    Dickinson BL; Clements JD
    Infect Immun; 1995 May; 63(5):1617-23. PubMed ID: 7729864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin.
    Douce G; Fontana M; Pizza M; Rappuoli R; Dougan G
    Infect Immun; 1997 Jul; 65(7):2821-8. PubMed ID: 9199455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of two novel nontoxic mutants of Escherichia coli heat-labile enterotoxin.
    Park EJ; Chang JH; Kim JS; Chung SI; Yum JS
    Exp Mol Med; 1999 Jun; 31(2):101-7. PubMed ID: 10410310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
    Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
    Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit.
    de Haan L; Verweij WR; Feil IK; Holtrop M; Hol WG; Agsteribbe E; Wilschut J
    Immunology; 1998 Jul; 94(3):424-30. PubMed ID: 9767427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin.
    de Haan L; Feil IK; Verweij WR; Holtrop M; Hol WG; Agsteribbe E; Wilschut J
    Eur J Immunol; 1998 Apr; 28(4):1243-50. PubMed ID: 9565364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity.
    Giuliani MM; Del Giudice G; Giannelli V; Dougan G; Douce G; Rappuoli R; Pizza M
    J Exp Med; 1998 Apr; 187(7):1123-32. PubMed ID: 9529328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin.
    Lobet Y; Cluff CW; Cieplak W
    Infect Immun; 1991 Sep; 59(9):2870-9. PubMed ID: 1908825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants.
    Douce G; Giannelli V; Pizza M; Lewis D; Everest P; Rappuoli R; Dougan G
    Infect Immun; 1999 Sep; 67(9):4400-6. PubMed ID: 10456880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunization.
    De Magistris MT; Pizza M; Douce G; Ghiara P; Dougan G; Rappuoli R
    Dev Biol Stand; 1998; 92():123-6. PubMed ID: 9554265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.
    Nawar HF; Arce S; Russell MW; Connell TD
    Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile toxin A carboxyl-terminus peptide lacking ADP-ribosyltransferase activity acts as a mucosal adjuvant.
    Castagliuolo I; Sardina M; Brun P; DeRos C; Mastrotto C; Lovato L; Palù G
    Infect Immun; 2004 May; 72(5):2827-36. PubMed ID: 15102793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli.
    Douce G; Giuliani MM; Giannelli V; Pizza MG; Rappuoli R; Dougan G
    Vaccine; 1998 Jul; 16(11-12):1065-73. PubMed ID: 9682360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants.
    McCluskie MJ; Weeratna RD; Clements JD; Davis HL
    Vaccine; 2001 Jun; 19(27):3759-68. PubMed ID: 11395211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses.
    Simmons CP; Hussell T; Sparer T; Walzl G; Openshaw P; Dougan G
    J Immunol; 2001 Jan; 166(2):1106-13. PubMed ID: 11145691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
    Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
    Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine.
    Hagiwar Y; Tsuji T; Iwasaki T; Kadowaki S; Asanuma H; Chen Z; Komase K; Suzuki Y; Aizawa C; Kurata T; Tamura S
    Vaccine; 2001 Feb; 19(15-16):2071-9. PubMed ID: 11228379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant.
    Di Tommaso A; Saletti G; Pizza M; Rappuoli R; Dougan G; Abrignani S; Douce G; De Magistris MT
    Infect Immun; 1996 Mar; 64(3):974-9. PubMed ID: 8641809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.